Viewing nowCombinationTD Combi Tablet 10/100 mg
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.

MFDS item code 202202644 · Approved 2022.06.15 · Insurance code 679802230
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is particularly effective when sitagliptin and dapagliflozin are administered together and is suitable for patients who are also following dietary modifications and exercise therapy. It helps improve blood sugar levels and supports overall diabetes management.
Patients receiving sitagliptin 100 mg and dapagliflozin 10 mg may take 1 tablet once daily, regardless of meals. Swallow the tablet whole. - No dose adjustment is necessary if the estimated glomerular filtration rate [estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication is a combination of sitagliptin and dapagliflozin. First, it is essential to check whether you have had an allergic reaction to any components in this medication before taking it. Allergic reactions can be severe and may manifest as skin rash, difficulty breathing, or swelling in the face or neck. This medication may cause severe side effects such as pancreatitis, which is inflammation of the pancreas. If abdominal pain, vomiting, or nausea occurs during use, consult a doctor immediately. There may be a rare complication known as diabetic ketoacidosis, so be aware of symptoms such as nausea, vomiting, abdominal pain, fatigue, and difficulty breathing. Ketoacidosis can occur even if blood sugar levels are within normal ranges, so report any symptoms to healthcare professionals immediately. This medication can affect kidney function, so it is advisable to avoid use in patients with kidney disease or those undergoing dialysis. Patients with reduced kidney function may need dosage adjustment, and regular kidney function tests are recommended. Dapagliflozin may cause fluid volume reduction and low blood pressure; therefore, elderly patients or those on diuretics should periodically monitor their blood pressure and fluid status. This medication may increase the risk of genital infections and urinary tract infections; if symptoms of infection (itching, pain, increased discharge, etc.) occur, inform a doctor and seek treatment immediately. It is safest for women who are pregnant or planning to become pregnant, as well as those breastfeeding, to avoid this medication. If pregnancy is confirmed, discontinue use immediately, and avoid use while breastfeeding as well. The safety and efficacy of this medication in children and adolescents under 18 years old have not been established, so use is not recommended. Taking this medication together with insulin or sulfonylureas may increase the risk of hypoglycemia; thus, caution for hypoglycemic symptoms and possible dosage adjustments are necessary when combined with these medications. In case of overdose, visit a medical facility immediately for appropriate treatment; dialysis is generally not recommended to remove this medication. Finally, exercise caution when driving or operating machinery while taking this medication, especially if hypoglycemic symptoms occur.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture ingress, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Yellow rectangular film-coated tablet
28 tablets/box [7 tablets/PTP X 4], 30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.